HGERS
TEVA icon

Householder Group Estate & Retirement Specialist’s Teva Pharmaceuticals TEVA Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300
Closed -$5K – 1146
2024
Q3 		$5K Buy
+300
New +$5.25K ﹤0.01% 942
2023
Q4 		– Sell
-30
Closed -$306 – 1324
2023
Q3 		$306 Buy
+30
New +$279 ﹤0.01% 1210
2023
Q1 		$0 Buy
+30
New +$297 ﹤0.01% 1303
2022
Q4 		– Sell
-30
Closed – – 1051
2022
Q3 		$0 Buy
+30
New +$265 ﹤0.01% 1193

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's TEVA Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist sold out of Teva Pharmaceuticals (TEVA) in Q4 2024, closing a stake of 300 shares — an estimated $5K sold.

Householder Group Estate & Retirement Specialist first reported a position in TEVA in Q3 2022 and held it in 4 quarters. The position peaked at $5K in Q3 2024. 584 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining Teva Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 300 Teva Pharmaceuticals shares in Q4 2024, an estimated $5K.
  • Householder Group Estate & Retirement Specialist first reported a position in Teva Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • Householder Group Estate & Retirement Specialist's Teva Pharmaceuticals position peaked at $5K in Q3 2024.
  • 584 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.